Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression (Q35925880)

11 August 2017

Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression (English)

1 reference

11 August 2017

0 references

4

Robert C Green

1 reference

11 August 2017

1

Michelle M Mielke

1 reference

11 August 2017

Constantine G. Lyketsos

8

object named as

Constantine G Lyketsos

1 reference

11 August 2017

Jeannie-Marie Leoutsakos

2

1 reference

11 August 2017

Chris D Corcoran

3

1 reference

11 August 2017

Maria C Norton

5

1 reference

11 August 2017

Kathleen A Welsh-Bohmer

6

1 reference

11 August 2017

JoAnn T Tschanz

7

1 reference

11 August 2017

1 February 2012

1 reference

11 August 2017

Alzheimer's and Dementia

1 reference

11 August 2017

8

1 reference

11 August 2017

3

1 reference

11 August 2017

180-187

1 reference

Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Longitudinal medication usage in Alzheimer disease patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Ethnic differences in acetylcholinesterase inhibitor use for Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Donepezil. Pharmacoeconomic implications of therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Sex differences and estrous cycle-variations in the AF64A-induced cholinergic deficit in the rat hippocampus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Vascular factors predict rate of progression in Alzheimer disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Identifying dementia in high-risk community samples: the memory and medical care study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

A new clinical scale for the staging of dementia.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3341471

Influence of premorbid IQ and education on progression of Alzheimer's disease

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22301194

12 December 2020

inferred from PubMed ID database lookup

Studies on Muscarinic Receptors in Mouse and Rat Hypothalamus: A Comparison of Sex and Cyclical Differences

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22301194

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/J.JALZ.2011.02.011

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2ftpybvkhjdc3d6tvmcgt4hvci

30 July 2022

release_2ftpybvkhjdc3d6tvmcgt4hvci

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2ftpybvkhjdc3d6tvmcgt4hvci

30 July 2022

https://api.fatcat.wiki/v0/release/2ftpybvkhjdc3d6tvmcgt4hvci

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/2ftpybvkhjdc3d6tvmcgt4hvci

PubMed publication ID

1 reference

30 July 2022